From: Stanisic, Nancy (CDER)
Sent: Tuesday, March 15, 2005 8:09 AM
To: Butler, Jennie C; Stanisic, Nancy (CDER); 'mandt@aspreva.com'
Subject: RE: Registration for a Meeting
We are not accepting any registrations at this time.  The room is currently oversubscribed by 50 people.  The meeting will be web cast by two firms- you may want to call them:
 
FDALive.com  301-984-0001
FDAadvisorycommittee.com  301-664-7210
 
 
-----Original Message-----
From: Lawrence Mandt [mailto:lmandt@aspreva.com]
Sent: Monday, March 14, 2005 5:04 PM
To: fdadockets@oc.fda.gov
Subject: Registration for a Meeting

I would like to attend the Public Hearing for the Reporting of Adverse Events to Institutional Review Boards being held March 21, 2005.  I tried to make a reservation online using the connection provided in the meeting notice, as well as the connection at the Dockets Page on the FDA website, but continued to get a message that there was no docket for the date requested.  Therefore, I am sending this email message to register to attend the meeting on March 21, 2005 if space is still available.

If there is some other procedure to follow, please advise.

Regards,

Larry

_____________________
Lawrence D. Mandt
Vice President, Regulatory Affairs
Aspreva Pharmaceuticals Corporation
#1203, 4464 Markham Street
Victoria, BC  V8Z 7X8 Canada

Tel: 1-250-744-2488, Ext. 256
Fax: 1-250-744-2498
lmandt@aspreva.com
www.aspreva.com

*************************************************************************
The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material.  Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient is prohibited.  If you received this in error, please contact the sender and delete the material from any computer.